
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+12
Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI) is a biopharmaceutical company focused on developing, manufacturing, and commercializing innovative inflammation and immunology (I&I) biological products primarily for the treatment of autoimmune and infectious diseases. With a state-of-the-art facility for biopharmaceutical product development and manufacturing and highly experienced pharmaceutical industry leadership, Scinai offers end-to-end boutique CDMO services in parallel to developing its own pipeline of diversified and commercially viable products and platforms beginning with an innovative nanosized VHH antibody (NanoAb) pipeline targeting diseases with large unmet medical needs. Company website: www.scinai.com
Biondvax,biotechnology,recombinant proteins,clinical trials,nasdaq,infectious diseases,pharmaceutical,pharmaceutical manufacturing,gmp,gxp,therapeutics,nanobodies,nanoabs,antibodies,cdmo,scinai,and immunotherapeutics
Scinai immunotherapeutics ltd operates in the Biotechnology research industry.
Scinai immunotherapeutics ltd's HQ phone number is 646-653-7030
Scinai immunotherapeutics ltd's revenue is 11m - 100m
Scinai immunotherapeutics ltd has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.